<HashMap><database>GEO</database><file_versions><headers><Content-Type>application/xml</Content-Type></headers><body><files><Other>ftp://ftp.ncbi.nlm.nih.gov/geo/series/GSE325nnn/GSE325333/</Other></files><type>primary</type></body><statusCode>OK</statusCode><statusCodeValue>200</statusCodeValue></file_versions><scores/><additional><omics_type>Transcriptomics</omics_type><species>Homo sapiens</species><gds_type>Expression profiling by high throughput sequencing</gds_type><full_dataset_link>https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE325333</full_dataset_link><repository>GEO</repository><entry_type>GSE</entry_type></additional><is_claimable>false</is_claimable><name>RNA-seq analysis of human peripheral blood Treg cells stratified into four equal fractions according to CD38 intensity</name><description>Sensitivity of regulatory T cells (Tregs) to extracellular nucleotides such as ATP and NAD⁺ differs substantially between mice and humans. Mouse Tregs undergo robust apoptosis in response to even low concentrations of ATP or NAD⁺, whereas human Tregs show markedly reduced sensitivity to these nucleotides. In our preliminary analyses, however, we observed that a subset of human Tregs expressing low levels of CD38 exhibited increased sensitivity to ATP/NAD⁺. To investigate the molecular mechanisms underlying this enhanced sensitivity, human peripheral blood Tregs were stratified into four fractions based on CD38 expression levels and subjected to RNA sequencing (RNA-seq) analysis.</description><dates><publication>2026/05/15</publication></dates><accession>GSE325333</accession><cross_references><GSM>GSM9600934</GSM><GSM>GSM9600923</GSM><GSM>GSM9600936</GSM><GSM>GSM9600925</GSM><GSM>GSM9600930</GSM><GSM>GSM9600932</GSM><GSM>GSM9600921</GSM><GSM>GSM9600927</GSM><GSM>GSM9600938</GSM><GSM>GSM9600929</GSM><GSM>GSM9600918</GSM><GSM>GSM9600919</GSM><GPL>24676</GPL><GSE>325333</GSE><taxon>Homo sapiens</taxon></cross_references></HashMap>